메뉴 건너뛰기




Volumn 10, Issue 4, 2000, Pages 259-265

Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)- 1-propargylxanthine) to rat striatal membranes - A new, selective antagonist radioligand for A(2A) adenosine receptors

Author keywords

A(2A) adenosine receptor antagonist; Adenosine receptors; Radioligand; Xanthine; 3H MSX 2

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; GUANOSINE TRIPHOSPHATE; MAGNESIUM CHLORIDE; RADIOLIGAND; XANTHINE DERIVATIVE; (H(3))3 (3 HYDROXYPROPYL) 7 METHYL 8 (M METHOXYSTYRYL) 1 PROPARGYLXANTHINE; (H(3))3-(3-HYDROXYPROPYL)-7-METHYL-8-(M-METHOXYSTYRYL)-1-PROPARGYLXANTHINE; ADENOSINE A2A RECEPTOR; STYRENE DERIVATIVE;

EID: 0033625399     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(00)00064-6     Document Type: Article
Times cited : (77)

References (28)
  • 1
    • 0343689522 scopus 로고    scopus 로고
    • 2A adenosine receptors in rat brain homogenates
    • 2A adenosine receptors in rat brain homogenates. Br. J. Pharmacol. 125:1999;27P.
    • (1999) Br. J. Pharmacol. , vol.125 , pp. 27P
    • Alexander, S.H.P.1
  • 4
    • 0017184389 scopus 로고
    • A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
    • Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
    • (1976) Anal. Biochem. , vol.72 , pp. 248-254
    • Bradford, M.1
  • 7
    • 0022544144 scopus 로고
    • Analogues of caffeine and theophylline: Effect of structural alterations on affinity at adenosine receptors
    • Daly J.W., Padgett W. L, Shamim M.T. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. J. Med. Chem. 29:1986;1305-1308.
    • (1986) J. Med. Chem. , vol.29 , pp. 1305-1308
    • Daly, J.W.1    Padgett, W.L.2    Shamim, M.T.3
  • 14
    • 0029915945 scopus 로고    scopus 로고
    • 1 adenosine receptor with receptor/G protein complexes in rat brain membranes
    • 1 adenosine receptor with receptor/G protein complexes in rat brain membranes. Mol. Pharmacol. 49:1996;915-926.
    • (1996) Mol. Pharmacol. , vol.49 , pp. 915-926
    • Lorenzen, A.1    Guerra, L.2    Vogt, H.3    Schwabe, U.4
  • 18
    • 2842546966 scopus 로고    scopus 로고
    • Adenosine receptor antagonists: Structures and potential therapeutic applications
    • Müller C.E., Stein B. Adenosine receptor antagonists: structures and potential therapeutic applications. Curr. Pharm. Design. 2:1996;501-530.
    • (1996) Curr. Pharm. Design , vol.2 , pp. 501-530
    • Müller, C.E.1    Stein, B.2
  • 19
    • 0028972629 scopus 로고
    • 1 adenosine receptor/G protein coupling: Identification of a membrane protein that stabilizes the association of the receptor/G protein complex
    • 1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex. Mol. Pharmacol. 48:1995;806-817.
    • (1995) Mol. Pharmacol. , vol.48 , pp. 806-817
    • Nanoff, C.1    Mitterauer, T.2    Roka, F.3    Hohenegger, M.4    FreiBmuth, M.5
  • 22
    • 0031833150 scopus 로고    scopus 로고
    • Adenosine receptors: New opportunities for future drugs
    • Poulsen S.-A., Quinn R.J. Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem. 6:1998;619-641.
    • (1998) Bioorg. Med. Chem. , vol.6 , pp. 619-641
    • Poulsen, S.-A.1    Quinn, R.J.2
  • 23
    • 0031754497 scopus 로고    scopus 로고
    • Receptors for purines and pyrimidines
    • Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-492.
    • (1998) Pharmacol. Rev. , vol.50 , pp. 413-492
    • Ralevic, V.1    Burnstock, G.2
  • 24
    • 0030611334 scopus 로고    scopus 로고
    • 2A receptor antagonists as new agents for the treatment of Parkinson's disease
    • 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol. Sci. 18:1997;338-344.
    • (1997) Trends Pharmacol. Sci. , vol.18 , pp. 338-344
    • Richardson, P.J.1    Kase, H.2    Jenner, P.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.